Revvity 6 may 2026 Revvity tops Q1 estimates and unveils plans to exit China immunodiagnostics - Indian Pharma Post
Agilent 6 may 2026 Assessing Agilent Technologies (A) Valuation After FDA Approval Of PD L1 Assay For KEYTRUDA - Yahoo Finance
Novo Nordisk 6 may 2026 ‘No change’ for CagriSema as Novo ditches single-chamber device - Fierce Biotech
Agilent 6 may 2026 Assessing Agilent Technologies (A) Valuation After FDA Companion Diagnostic Approval For Esophageal Cancer - simplywall.st
Agilent 6 may 2026 Assessing Agilent Technologies (A) Valuation After FDA Companion Diagnostic Approval For Esophageal Cancer - simplywall.st
Lonza News 6 may 2026 Fine Chemicals Market Dominated by Europe | Lonza, Evonik, SRF Drive Pharma & Specialty Growth - openPR.com
Brady Corporation 6 may 2026 Brady unveils cordless industrial label printing solution - African Review
Recursion 6 may 2026 Recursion Pharmaceuticals Stock (RXRX) Opinions on Q1 2026 Earnings - Quiver Quantitative
Recursion 6 may 2026 Recursion Reports First Quarter Financial Results and Provides Business Update - markets.businessinsider.com